Breaking News, Collaborations & Alliances

VGXI Achieves Tech Transfer Milestones

Relates to RNA manufacturing partnership with research inst. in Houston

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Texas-based contract manufacturing organization (CMO) VGXI has completion initial tech transfer milestones as part of its partnership agreement for the production of RNA therapeutics with the Houston Methodist Research Institute (HMRI).   Under a license agreement with HMRI for development of clinical grade RNA manufacturing services, VGXI has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019. The plan includes establishment and operation of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters